[Driving ability after reversal of phenylephrine 10% induced mydriasis by dapiprazole 0.5%; a prospective study on 65 eyes].

@article{Schmidbauer2000DrivingAA,
  title={[Driving ability after reversal of phenylephrine 10% induced mydriasis by dapiprazole 0.5%; a prospective study on 65 eyes].},
  author={Josef M Schmidbauer and Thomas Georg and M R M{\"o}ller and Klaus W. Ruprecht},
  journal={Klinische Monatsblatter fur Augenheilkunde},
  year={2000},
  volume={217 6},
  pages={340-4}
}
BACKGROUND Particularly outpatients want to reach the ability for driving a car as soon as possible after pupillary dilatation. Dapiprazole is an alpha-1 adrenergic inhibitor that antagonizes the mydriatic effect of phenylephrine in a direct competitive way. The aim of this study was to determine restoration of traffic related functions after dapiprazole… CONTINUE READING